Featured Research

from universities, journals, and other organizations

Cat allergy vaccine safe and effective, study suggests

Date:
April 1, 2011
Source:
McMaster University
Summary:
Mark Larché and his research team have developed a cat allergy vaccine which is effective and safe with almost no side effects.

Mark Larché, professor in the Department of Medicine in the Michael G. DeGroote School of Medicine and Canada Research Chair in Allergy & Immune Tolerance.
Credit: Image courtesy of McMaster University

Good-bye itching, watering eyes and sneezing. McMaster University researchers have developed a vaccine which successfully treats people with an allergy to cats.

Related Articles


Traditionally, frequent allergy shots have been considered the most effective way to bring relief -- other than getting rid of the family pet -- for the eight to 10% of the population allergic to cats.

Both options -- one difficult and costly, the other troubling -- may now be tossed aside thanks to the work of immunologist Mark Larché, professor in the Department of Medicine in the Michael G. DeGroote School of Medicine and Canada Research Chair in Allergy & Immune Tolerance.

Building on research he's conducted for the past 10 years in Canada and Britain, Larché and his research team have developed a vaccine which is effective and safe with almost no side effects. The research is published in a recent (January 2011) issue of the Journal of Allergy & Clinical Immunology.

The researchers took one protein (molecule) that cats secrete on their fur which causes the majority of allergic problems. Using blood samples from 100 patient volunteers allergic to cats, they deconstructed the molecule and identified short regions within the protein which activate T-cells (helper cells that fight infection) in the immune system.

Using the amino acid code for the whole protein, researchers made synthetic versions of these regions. For the cat allergy vaccine, they found seven peptides (strings of amino acids). "And those synthetic peptides are what we mix together to make the vaccine," said Larché. "We picked the peptides that would work in as much of the population as possible."

Known as "peptide immunotherapy," a low dose of the vaccine is given into the skin. Initially, four to eight doses a year may be required, but the side effects of the traditional allergy shots do not arise, Larché said. The optimal dose will be determined in phase three clinical trials which are getting underway with a much larger group of cat allergy sufferers.

The development of a vaccine to treat people allergic to cats is the first in a line of vaccines developed with Adiga Life Sciences, a company established at McMaster in 2008. It is a joint venture between McMaster University and Circassia Ltd., a UK-based biotech company.

Adiga and McMaster are now collaborating on research into the use of peptide immunotherapy for house dust mite, ragweed, grass, birch tree and moulds.


Story Source:

The above story is based on materials provided by McMaster University. The original article was written by Suzanne Morrison. Note: Materials may be edited for content and length.


Journal Reference:

  1. M. Larché, H. Lee, J. Kleine-Tebbe, R.P. Hafner, P. Laidler, D. Healey, C. Buhot, A. Verhoef, B. Maillère, A.B. Kay. Development and Preliminary Clinical Evaluation of a Peptide Immunotherapy Vaccine for Cat Allergy. Journal of Allergy and Clinical Immunology, 2011; 127 (2): AB219 DOI: 10.1016/j.jaci.2010.12.870

Cite This Page:

McMaster University. "Cat allergy vaccine safe and effective, study suggests." ScienceDaily. ScienceDaily, 1 April 2011. <www.sciencedaily.com/releases/2011/03/110331163534.htm>.
McMaster University. (2011, April 1). Cat allergy vaccine safe and effective, study suggests. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2011/03/110331163534.htm
McMaster University. "Cat allergy vaccine safe and effective, study suggests." ScienceDaily. www.sciencedaily.com/releases/2011/03/110331163534.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
Toxin-Packed Stem Cells Used To Kill Cancer

Toxin-Packed Stem Cells Used To Kill Cancer

Newsy (Oct. 25, 2014) — A Harvard University Research Team created genetically engineered stem cells that are able to kill cancer cells, while leaving other cells unharmed. Video provided by Newsy
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins